Brooks O'Neil

Stock Analyst at Lake Street

(1.03)
# 3,882
Out of 5,040 analysts
36
Total ratings
32.35%
Success rate
-12.08%
Average return

Stocks Rated by Brooks O'Neil

Tandem Diabetes Care
Aug 11, 2025
Downgrades: Hold
Price Target: $75$12
Current: $14.66
Upside: -18.14%
AVITA Medical
Aug 11, 2025
Maintains: Buy
Price Target: $14$8
Current: $4.02
Upside: +99.00%
LifeMD
Aug 6, 2025
Maintains: Buy
Price Target: $18$14
Current: $6.23
Upside: +124.72%
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50$20
Current: $8.88
Upside: +125.23%
Surmodics
Mar 7, 2025
Upgrades: Buy
Price Target: $43
Current: $27.47
Upside: +56.53%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105$110
Current: $89.01
Upside: +23.58%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $20.02
Upside: +49.89%
Semler Scientific
Jan 24, 2025
Maintains: Buy
Price Target: $40$71
Current: $22.76
Upside: +211.95%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $8.82
Upside: +194.78%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45$55
Current: $39.04
Upside: +40.88%
Maintains: Buy
Price Target: $32$18
Current: $15.89
Upside: +13.28%
Initiates: Buy
Price Target: $5
Current: $4.11
Upside: +21.65%
Initiates: Buy
Price Target: $12
Current: $6.64
Upside: +80.72%
Maintains: Buy
Price Target: $20$26
Current: $24.69
Upside: +5.31%
Initiates: Buy
Price Target: $11
Current: $0.56
Upside: +1,872.39%
Initiates: Buy
Price Target: $128
Current: $31.37
Upside: +306.44%